OCRHIPAA Privacy Rule

HIPAA Treatment, Payment, and Operations (45 CFR 164.506)

Covered entities may use and disclose PHI for treatment, payment, and health care operations without authorization, subject to limits and notice requirements.

Primary source

45 CFR 164.506 — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-E/section-164.506

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

Additional sources

45 CFR 164.506 is the workhorse of the Privacy Rule: a covered entity may use or disclose PHI for its own treatment, payment, and health care operations (TPO) without obtaining an authorization. It may also disclose PHI to another covered entity for that entity's treatment activities, for payment activities, or for limited health care operations purposes when both entities have a relationship with the individual.

"Treatment" includes provision, coordination, or management of care, consultations, and referrals. "Payment" covers billing, claims management, collection, premium calculation, and similar activities. "Health care operations" is the broadest category — quality assessment, case management, credentialing, training, business planning, and certain audits.

The minimum necessary standard applies to TPO except for treatment-related disclosures to other providers. The Notice of Privacy Practices required by 164.520 must describe the TPO uses. Practices must also honor any reasonable restriction requests they have agreed to under 164.522(a).

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.